相关临床试验
5
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
已完成
4
80.0%
招募中
1
20.0%
暂无批准数据
- Quantum Surgical has acquired NeuWave Medical from Johnson & Johnson to strengthen its robotic-assisted tumor ablation capabilities for cancer treatment. - NeuWave's microwave ablation technology is currently used by physicians in over 70% of the top U.S. cancer centers for percutaneous tumor ablation procedures. - The acquisition creates Precision IO Group under CEO Kurt Azarbarzin, with plans to develop remote intervention capabilities that could expand access to specialized cancer care globally. - Quantum's Epione robotic platform has already treated more than 1,400 patients across Europe and the United States, with FDA clearance for abdominal ablation procedures.
- The Philips-coordinated PreciseOnco consortium has been awarded €14.9 million in EU funding to develop integrated spectral imaging, robotic guidance, and AI technologies for minimally invasive cancer treatment. - The five-year research program will conduct five clinical studies across multiple cancer types to validate spectral imaging and robotic guidance systems with sub-millimeter precision. - The initiative addresses the growing cancer burden, with projections of over 35 million new cases globally by 2050, representing a 77% increase from 2022. - The consortium unites leading European hospitals, research organizations, and industry partners to standardize and enhance precision in interventional oncology procedures.
